Cleared Traditional

K182756 - MyoStrain 5.1

K182756 is the FDA 510(k) clearance for MyoStrain 5.1 by Myocardial Solutions. It is a Class 2 Radiology device (product code LNH) cleared through the Traditional 510(k) pathway after a 139-day FDA review.

K182756 · Myocardial Solutions · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2019
Decision
139d
Days
Class 2
Risk

K182756 is an FDA 510(k) clearance for the MyoStrain 5.1. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Myocardial Solutions (Morrisville, US). The FDA issued a Cleared decision on February 14, 2019 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Myocardial Solutions devices

Submission Details

510(k) Number K182756 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2018
Decision Date February 14, 2019
Days to Decision 139 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 107d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 812
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K182756.
EMMA 1.5T MRI System
K183621 · Time Medical Limited · Feb 2019
MAGNETOM Terra
K183222 · Siemens Medical Solutions USA, Inc. · Feb 2019
MAGNETOM Aera
K190138 · Siemens Medical Solutions USA, Inc. · Feb 2019
Ingenia, Ingenia CX, Ingenia Elition, and Ingenia Ambition MR Systems
K183063 · Philips Medical Systems Nederland B.V. · Feb 2019
MAGNETOM Amira, MAGNETOM Sempra
K183221 · Siemens Medical Solutions USA, Inc. · Feb 2019
MAGNETOM Lumina
K183244 · Siemens Medical Solutions USA, Inc. · Jan 2019